Nafamostat mesilate, a nuclear factor kappa B inhibitor, enhances the antitumor action of radiotherapy on gallbladder cancer cells

• Naoki Takada ,

  Roles Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review & editing

  * E-mail: naoki-takada@jikei.ac.jp

  Affiliations Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan, Division of Gene Therapy, Research Center for Medical Science, The Jikei University School of Medicine, Tokyo, Japan

  https://orcid.org/0000-0003-3192-7979

  ⨯
• Hiroshi Sugano,

  Roles Formal analysis, Investigation, Methodology, Writing – review & editing

  Affiliations Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan, Division of Gene Therapy, Research Center for Medical Science, The Jikei University School of Medicine, Tokyo, Japan

  ⨯
• Yoshihiro Shirai,

  Roles Conceptualization, Formal analysis, Methodology, Writing – review & editing

  Affiliations Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan, Division of Gene Therapy, Research Center for Medical Science, The Jikei University School of Medicine, Tokyo, Japan

  ⨯
• Nobuhiro Saito,

  Roles Formal analysis, Investigation, Methodology

  Affiliation Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan

  https://orcid.org/0000-0001-6795-4093

  ⨯
• Ryoga Hamura,

  Roles Formal analysis, Investigation, Methodology

  Affiliations Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan, Division of Gene Therapy, Research Center for Medical Science, The Jikei University School of Medicine, Tokyo, Japan

  ⨯
• Tomohiko Taniai,

  Roles Formal analysis, Investigation, Methodology

  Affiliations Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan, Division of Gene Therapy, Research Center for Medical Science, The Jikei University School of Medicine, Tokyo, Japan

  ⨯
• Tadashi Uwagawa,

  Roles Writing – review & editing

  Affiliations Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan, Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan

  ⨯
• Katsuhiko Yanaga,

  Roles Supervision, Writing – review & editing

  Affiliation Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan

  https://orcid.org/0000-0001-8918-4720

  ⨯
• Toru Ikegami,

  Roles Supervision

  Affiliation Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan

  ⨯
• Toya Ohashi,

  Roles Project administration, Supervision

  Affiliation Division of Gene Therapy, Research Center for Medical Science, The Jikei University School of Medicine, Tokyo, Japan

  ⨯
• Ken Eto

  Roles Project administration, Supervision

  Affiliation Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan

  ⨯